Effect of Hypoxia on the Activation and Visfatin Expression in Rat Hepatic Stellate Cells
Abstract
To investigate the effect of hypoxia on the visfatin and the expression of smooth muscle-actin (α-SMA) and hypoxia-inducible factor-1α (HIF-1α) in rat hepatic stellate cells (HSCs). Methods Rat primary HSCs were isolated from SD rats by in situ perfusion of collagenase and pronase and single-step Nycodenz density gradient centrifugation, and then cultured and activated. Completely activated primary HSCs were exposed to hypoxic conditions (37 ℃, 5% CO2, 1% O2,94%N2), or normoxic conditions (37 ℃, 5% CO2, 21% O2,74% N2), for 3, 6, 12 or 24 h respectively. The expression of α-SMA, the marker of HSC activation, and visfatin were assessed by Real time-PCR and Western blot. The Expression of HIF-1α was detected by Real time-PCR. Results HIF-1α mRNA in rat HSCs was induced after exposed to hypoxia for 3 h, and maintained elevated status up to 24 h. HSCs exposed to 1% O2 hypoxic conditions for 6 h increased α-SMA mRNA and protein expression. Visfatin mRNA expression was up-regulated after subjected to hypoxia for 12 h, and protein level was elevated after 6 h hypoxia. A positive linear correlation existed between α-SMA and visfatin expression in responsible to hypoxia 〔r=0.991 (genes) and r=0.968 (proteins),P<0.05〕. Conclusion Microcirculation impairment could significantly induce α-SMA and visfatin expression in rat HSCs, which might potentate the activation process of HSCs.
Keywords: Hepatic stellate cells, Hypoxia-inducible factor-1α, Visfatin α-smooth muscle actin
Full Text:
PDFReferences
Jarrar MH. Baranova А, Collantes R, et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther, 2008; 27(5); 412-421.
Procaccini C. Galgani M. De Rosa V. et al. Leptin: the prototypic adipocytokine and its role in NAFLD. Curr Pharm Des,2010;16(17):1902-1912.
Boyraz M, Cekmez F. Karaoglu A ,et al. Serum adiponectin. leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease. Biomark Med,2013;7(5) :737-745.
Stastny J. Bienertova-Vasku J, Vasku A, et al. Visfatin and its role in obesity development. Diabetes Metab Syndr.2012;6(2): 120-124.
Romanowska A. Lebensztejn DM. Evaluation of serum visfatin concentrations in children with nonalcoholic fatty. Pol Merkur Lekarski,2010;28( 168):459-461.
Farrell Geoff C. Teoh NC. McCuskey RS. Hepatic microcirculation in fatty liver disease. Anat Rec, 2008; 291 ( 6): 684-692.
Zhu Y, Men R, Wen M. et al. Blockage of TRPM7 channel induces hepatic stellate cell death through endoplasmic. Life Sci.2014 ;94(1):37-44 .
Rombouts K, Marra F. Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. Dig Dis, 2010; 28( 1): 229-235.
Shi YF, Fong CC, Zhang Q , et al. Hypoxia induces the activation of human hepatic stellate cells LX-2 through TGF- beta signaling pathway. FEBS Lett ,2007;581 (2);203-210.
Wang B. Lin C, Wu G, et al. Tumor necrosis factor-alpha enhances hyperbaric oxygen-induced visfatin expression via JNK pathway in human coronary arterial endothelial cells. J Biomed Sci,2011; 18;27. doi;10. 1186/1423-0127-18-27.
Bae SK. Kim SR. Kim JC, et al. Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1. FEBS Lett, 2006;580(17) s4105-4113.
Segawa K. Fukubara A. Hosogai N. et al. Visfatin in adipocytes is upregulated by hypoxia through HIF 1 «-dependent mechanism. Biochem Biophys Res Commun» 2006 ; 349С 3): 875- 882.
Kukla M, CiupinskaKajor M. Kajor M, et al. Liver visfatin expression in morbidly obese patients with nonalcoholic fatty. Pol J Pathol,2010;61(3): 147-153.
Refbacks
- There are currently no refbacks.



